Skip to main content
. 2010 Oct 7;2010:174354. doi: 10.4061/2010/174354

Table 1.

Potential enzyme therapies for celiac disease.

Target for detoxification Detoxifying agent Mechanism of action Status of research
Ingested gliadin peptides Prolyl endopeptidases from: Hydrolysis of proline-rich peptides of gliadin Preclinical
S. capsulate [49]
F. meningosepticum [50]
M. xanthus [51]
Prolyl endopeptidases from: A. niger [52] Clinical trial
Prolyl endopeptidases from: S. capsulate in combination with a glutamine-specific endoprotease (EP)-B2 from germinating barley [53] Clinical trial

Flour Sourdough lactobacilli-derived peptidases [56] Hydrolysis of proline-rich peptides of gliadin Clinical trial
Sourdough lactobacilli-derived peptidases in combination with fungal proteases [64] Clinical trial

Flour Transglutaminase enzymes [67] Transamidation of gliadin peptides with lysine methyl ester Preclinical

Mucosal tTG Irreversible thiol-reactive reagents, competitive peptidic, and nonpeptidic substrates [69] unspecific or specific tTG inhibition Preclinical